Clare Cutland to Meningococcal Vaccines
This is a "connection" page, showing publications Clare Cutland has written about Meningococcal Vaccines.
Connection Strength
1,603
-
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5?years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children. Vaccine. 2023 01 27; 41(5):1153-1160.
Score: 0,833
-
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine. 2018 03 27; 36(14):1908-1916.
Score: 0,595
-
Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials. Pediatr Infect Dis J. 2020 07; 39(7):641-644.
Score: 0,175